Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DOFETILIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 157 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cobbe, SM; Campbell, RWF; Camm, AJ; Nathan, AW; Rowland, E; Bloch-Thomsen, PE; Moller, M; Jordaens, L
      Effects of intravenous dofetilide on induction of atrioventricular re-entrant tachycardia

      HEART
    2. Tran, A; Vichiendilokkul, A; Racine, E; Milad, A
      Practical approach to the use and monitoring of dofetilide therapy

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    3. Restivo, M; Hegazy, M; El-Hamami, M; Yin, H; Caref, EB; Assadi, MA; Brooks, RR; El-Sherif, N
      Efficacy of azimilide and dofetilide in the dog right atrial enlargement model of atrial flutter

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    4. Skold, AC; Danielsson, BR
      Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol

      PHARMACOLOGY & TOXICOLOGY
    5. Saliba, WI
      Dofetilide (Tikosyn): A new drug to control atrial fibrillation

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    6. Al-Dashti, R; Sami, M
      Dofetilide: A new class III antiarrhythmic agent

      CANADIAN JOURNAL OF CARDIOLOGY
    7. Li, HT; Wang, YQ; Dai, DZ; Kong, RZ
      Frequency dependent prolongation of effective refractory period by a complex class III antiarrhythmic agent CPU-86017

      ACTA PHARMACOLOGICA SINICA
    8. Saoudi, N; Rinaldi, JP; Yaici, K; Bergonzi, M
      Dofetilide: What role in the treatment of ventricular tachyarrhythmias?

      EUROPEAN HEART JOURNAL
    9. Boriani, G; Lubinski, A; Capucci, A; Niederle, P; Kornacewicz-Jack, Z; Wnuk-Wojnar, AM; Borggrefe, M; Brachmann, J; Biffi, M; Butrous, GS
      A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease

      EUROPEAN HEART JOURNAL
    10. Sugiyama, A; Satoh, Y; Hashimoto, K
      Electropharmacologic effects of a new phosphodiesterase III inhibitor, toborinone (OPC-18790), assessed in an in vivo canine model

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    11. Kovacs, A; Gyonos, I; Magyar, J; Banyasz, T; Nanasi, PP; Spedding, M; Szenasi, G
      Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    12. Krahn, AD; Klein, GJ; Yee, R
      A randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of intravenously administered dofetilide in patients with Wolff-Parkinson-White syndrome

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    13. Skold, AC; Wellfelt, K; Danielsson, BR
      Stage-specific skeletal and visceral defects of the I-Kr-Blocker almokalant: Further evidence for teratogenicity via a hypoxia-related mechanism

      TERATOLOGY
    14. Kamiya, K; Mitcheson, JS; Yasui, K; Kodama, I; Sanguinetti, MC
      Open channel block of HERG K+ channels by vesnarinone

      MOLECULAR PHARMACOLOGY
    15. Zhang, ST; Rajamani, S; Chen, YM; Gong, QM; Rong, YJ; Zhou, ZF; Ruoho, A; January, CT
      Cocaine blocks HERG, but not KvLQT1+minK, potassium channels

      MOLECULAR PHARMACOLOGY
    16. O'Leary, ME
      Inhibition of human ether-a-go-go potassium channels by cocaine

      MOLECULAR PHARMACOLOGY
    17. Preobrazhensky, DV; Sidorenko, BA
      Successes and failures in elaboration of novel approaches to drug treatment of chronic heart failure (review of results of randomized trials conducted in the ninetieths). Part IV

      KARDIOLOGIYA
    18. Finlayson, K; Turnbull, L; January, CT; Sharkey, J; Kelly, JS
      [H-3]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen

      EUROPEAN JOURNAL OF PHARMACOLOGY
    19. Dumotier, BM; Bastide, M; Adamantidis, MM
      "Use-dependent" effects of cisapride on postrest action potentials in rabbit ventricular myocardium

      EUROPEAN JOURNAL OF PHARMACOLOGY
    20. Finlayson, K; Pennington, AJ; Kelly, JS
      [H-3]Dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?

      EUROPEAN JOURNAL OF PHARMACOLOGY
    21. Li, DS; Zhang, LM; Kneller, J; Nattel, S
      Potential ionic mechanism for repolarization differences between canine right and left atrium

      CIRCULATION RESEARCH
    22. Xu, XP; Rials, SJ; Wu, Y; Salata, JJ; Liu, TX; Bharucha, DB; Marinchak, RA; Kowey, PR
      Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbits

      CIRCULATION
    23. Derakhchan, K; Villemaire, C; Talajic, M; Nattel, S
      The class III antiarrhythmic drugs dofetilide and sotalol prevent AF induction by atrial premature complexes at doses that fail to terminate AF

      CARDIOVASCULAR RESEARCH
    24. Amos, GJ; Abrahamsson, C; Duker, G; Hondeghem, L; Palmer, M; Carlsson, L
      Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential

      CARDIOVASCULAR RESEARCH
    25. Barrett, TD; Hennan, JK; Fischbach, PS; O'Neill, BP; Driscoll, EM; Lucchesi, BR
      Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence

      BRITISH JOURNAL OF PHARMACOLOGY
    26. MacGowan, GA
      Clinical overview of the novel inotropic agent toborinone

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    27. Torp-Pedersen, C; Brendorp, B; Kober, L
      Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    28. Houltz, B; Darpo, B; Swedberg, K; Blomstrom, P; Crijns, HJGM; Jensen, SM; Svernhage, E; Edvardsson, N
      Comparison of QT dispersion during atrial fibrillation and sinus rhythm inthe same patients, at normal and prolonged ventricular repolarization

      EUROPACE
    29. Dorian, P
      Mechanisms of action of class III agents and their clinical relevance

      EUROPACE
    30. Kalus, JS; Mauro, VF
      Dofetilide: A class III-specific antiarrhythmic agent

      ANNALS OF PHARMACOTHERAPY
    31. Xie, JT; Yuan, CS; Zhou, Z; January, CT
      Enhancement of delayed afterdepolarizations and triggered activity by class III antiarrhythmic drugs: Multiple effects of E-4031 and dofetilide

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    32. Barajas-Martinez, H; Elizalde, A; Sanchez-Chapula, JA
      Developmental differences in delayed rectifying outward current in feline ventricular myocytes

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    33. Allen, MJ; Nichols, DJ; Oliver, SD
      The pharmacokinetics and pharmacodynamics of oral dofetilide after twice daily and three times daily dosing

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    34. Abel, S; Nichols, DJ; Brearley, CJ; Eve, MD
      Effcet of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    35. Bauer, A; Becker, R; Freigang, KD; Senges, JC; Voss, F; Kraft, P; Kuebler, W; Schoels, W
      Electrophysiologic effects of the new I-Ks-blocking agent chromanol 293b in the postinfarction canine heart - Preserved positive use-dependence and preferential prolongation of refractoriness in the infarct zone

      BASIC RESEARCH IN CARDIOLOGY
    36. Lenz, TL; Hilleman, DE
      Dofetilide, a new class III antiarrhythmic agent

      PHARMACOTHERAPY
    37. Bianconi, L; Castro, A; Dinelli, M; Alboni, P; Pappalardo, A; Richiardi, E; Santini, M
      Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter - A multicentre, randomized, double-blind, placebo-controlled study

      EUROPEAN HEART JOURNAL
    38. Pool, PE; Singh, SN; Friedrich, T
      Effects of intravenous dofetilide in patients with frequent premature ventricular contractions: A clinical trial

      CLINICAL CARDIOLOGY
    39. Marschang, H; Brachmann, J; Karolyi, L; Kubler, W; Schols, W
      Isoproterenol specifically modulates reverse rate-dependent effects of d,l-sotalol, d-sotalol, and dofetilide

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    40. Lenz, TL; Hilleman, DE
      Dofetilide: A new antiarrhythmic agent approved for conversion and/or maintenance of atrial fibrillation/atrial flutter

      DRUGS OF TODAY
    41. Heath, BM; Terrar, DA
      Protein kinase C enhances the rapidly activating delayed rectifier potassium current, I-Kr, through a reduction in C-type inactivation in guinea-pig ventricular myocytes

      JOURNAL OF PHYSIOLOGY-LONDON
    42. Gillis, AM; Mathison, HJ; Kulisz, E; Lester, WM
      Dispersion of ventricular repolarization and ventricular fibrillation in left ventricular hypertrophy: Influence of selective potassium channel blockers

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    43. Overholt, JL; Ficker, E; Yang, TE; Shams, H; Bright, GR; Prabhakar, NR
      HERG-like potassium current regulates the resting membrane potential in glomus cells of the rabbit carotid body

      JOURNAL OF NEUROPHYSIOLOGY
    44. Mitcheson, JS; Chen, J; Sanguinetti, MC
      Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate

      JOURNAL OF GENERAL PHYSIOLOGY
    45. Takahashi, N; Ito, M; Ishida, S; Fujino, T; Nakagawa, M; Yonemochi, H; Iwao, T; Ooie, T; Hara, M; Saikawa, T; Sakata, T
      Preceding stimulus frequency-dependent potentiation of the postrest shortening of the action potential duration in rabbits

      JAPANESE HEART JOURNAL
    46. Ulens, C; Tytgat, J
      Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation

      FEBS LETTERS
    47. Mounsey, JP; DiMarco, JP
      Dofetilide

      CIRCULATION
    48. Li, DS; Benardeau, A; Nattel, S
      Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation

      CIRCULATION
    49. Rouet, R; Picard, S; Libersa, C; Ghadanfar, M; Alabaster, C; Gerard, JL
      Electrophysiological effects of dofetilide in an in vitro model of "borderzone" between normal and ischemic/reperfused myocardium

      CIRCULATION
    50. Skold, AC; Danielsson, BR
      Developmental toxicity of the class III antiarrhythmic agent almokalant inmice - Adverse effects mediated via induction of embryonic heart rhythm abnormalities

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    51. Falk, RH; DeCara, JM
      Dofetilide: A new pure class III antiarrhythmic agent

      AMERICAN HEART JOURNAL
    52. Dhein, S
      Drug-induced QT prolongation and torsade de pointes arrhythmias

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    53. Crumb, W; Cavero, I
      QT interval prolongation by noncardiovascular drugs: issues and solutions for novel drug development

      PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY
    54. Camm, AJ; Yap, YG
      What should we expect from the next generation of antiarrhythmic drugs?

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    55. Drolet, B; Zhang, ST; Deschenes, D; Rail, J; Nadeau, S; Zhou, ZG; January, CT; Turgeon, J
      Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    56. Houltz, B; Darpo, B; Swedberg, K; Blomstrom, P; Brachmann, J; Crijns, HJGM; Jensen, SM; Svernhage, E; Vallin, H; Edvardsson, N
      Effects of the I-kr-blocker almokalant and predictors of conversion of chronic atrial tachyarrhythmias to sinus rhythm. A prospective study

      CARDIOVASCULAR DRUGS AND THERAPY
    57. Choy, AMJ; Darbar, D; Dell'Orto, S; Roden, DM
      Exaggerated QT prolongation after cardioversion of atrial fibrillation

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    58. Sager, PT
      New advances in class III antiarrhythmic drug therapy

      CURRENT OPINION IN CARDIOLOGY
    59. Mehdirad, AA; Carnes, CA; Nelson, SD
      The influence of specific and nonspecific potassium current blockade on the defibrillation energy requirement of biphasic shock

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    60. Melichercik, J; Brachmann, J; Schols, W; Hilbel, T; Beyer, T; Kubler, W
      Rate and time dependent effects of D-sotalol on the monophasic action potential after sudden increase of the heart rate

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    61. Smoak, IW
      Cromakalim: Embryonic effects and reduction of tolbutamide-induced dysmorphogenesis in vitro

      TERATOLOGY
    62. Satoh, Y; Sugiyama, A; Tamura, K; Hashimoto, K
      Effects of a class III antiarrhythmic drug, dofetilide, on the in situ canine heart assessed by the simultaneous monitoring of hemodynamic and electrophysiological parameters

      JAPANESE JOURNAL OF PHARMACOLOGY
    63. D'Alonzo, AJ; Zhu, JL; Darbenzio, RB
      Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe

      EUROPEAN JOURNAL OF PHARMACOLOGY
    64. McClellan, KJ; Markham, A
      Dofetilide - A review of its use in atrial fibrillation and atrial flutter

      DRUGS
    65. Zhang, ST; Zhou, ZF; Gong, QM; Makielski, JC; January, CT
      Mechanism of block and identification of the verapamil binding domain to HERG potassium channels

      CIRCULATION RESEARCH
    66. van Ginneken, ACG; Veldkamp, MW
      Implications of inhomogeneous distribution of I-KS and I-KR channels in ventricle with respect to effects of class III agents and beta-agonists

      CARDIOVASCULAR RESEARCH
    67. Walker, BD; Singleton, CB; Bursill, JA; Wyse, KR; Valenzuela, SM; Qiu, MR; Breit, SN; Campbell, TJ
      Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states

      BRITISH JOURNAL OF PHARMACOLOGY
    68. Wang, HZ; Shi, H; Wang, ZG
      Inactivation block of the HERG human cardiac K+ channels by RP58866

      BRITISH JOURNAL OF PHARMACOLOGY
    69. Walker, BD; Valenzuela, SM; Singleton, CB; Tie, H; Bursill, JA; Wyse, KR; Qiu, MR; Breit, SN; Campbell, TJ
      Inhibition of HERG channels stably expressed in a mammalian cell line by the antianginal agent perhexiline maleate

      BRITISH JOURNAL OF PHARMACOLOGY
    70. Williams, BA; Dickenson, DR; Beatch, GN
      Kinetics of rate-dependent shortening of action potential duration in guinea-pig ventricle; effects of I-K1 and I-Kr blockade

      BRITISH JOURNAL OF PHARMACOLOGY
    71. Ellenbogen, KA; Wood, MA; Stambler, BS
      Intravenous therapy for atrial fibrillation: More choices, more questions,more trials

      AMERICAN HEART JOURNAL
    72. TSIKOURIS JP
      FOCUS ON DOFETILIDE - A SELECTIVE CLASS-III ANTIARRHYTHMIC AGENT FOR USE IN ATRIAL-FIBRILLATION OR ATRIAL-FLUTTER

      Formulary (Cleveland, Ohio)
    73. CAPUCCI A; VILLANI GQ; ASCHIERI D; PIEPOLI M
      EFFECTS OF CLASS-III DRUGS ON ATRIAL-FIBRILLATION

      Journal of cardiovascular electrophysiology
    74. MILLER KE; CARPENTER JF; BROOKS RR
      INHIBITION OF ISOPROTERENOL-INDUCED TACHYCARDIA BY AZIMILIDE IN THE ISOLATED-PERFUSED GUINEA-PIG HEART

      Cardiovascular drugs and therapy
    75. Marschang, H; Beyer, T; Karolyi, L; Kubler, W; Brachmann, J
      Differential rate and potassium dependent effects of class III agents d-sotalol and dofetilide on guinea pig papillary muscle

      CARDIOVASCULAR DRUGS AND THERAPY
    76. XUE YX; TANABE S; NABUCHI Y; HASHIMOTO K
      ANTIARRHYTHMIC EFFECTS OF A NOVEL CLASS-III DRUG, KCB-328, ON CANINE VENTRICULAR ARRHYTHMIA MODELS

      Journal of cardiovascular pharmacology
    77. MARSCHANG H; SCHOLS W; KAROLYI L; BEYER T; KUBLER W; BRACHMANN J
      DIFFERENTIAL-EFFECTS OF D-SOTALOL ON SUBENDOCARDIAL PURKINJE MYOCYTESISOLATED FROM NORMAL OR 10 TO 14 DAYS POSTINFARCTION CANINE HEARTS - ROLE OF EXTRACELLULAR POTASSIUM CONCENTRATION

      Journal of cardiovascular pharmacology
    78. FAIVRE JF; ROUANET S; BRIL A
      COMPARATIVE EFFECTS OF GLIBENCLAMIDE, TEDISAMIL, DOFETILIDE, E-4031, AND BRL-32872 ON PROTEIN-KINASE A-ACTIVATED CHLORIDE CURRENT IN GUINEA-PIG VENTRICULAR MYOCYTES

      Journal of cardiovascular pharmacology
    79. LEE KH; LEE JY; KIM HY; KWON LS; SHIN HS; TANABE S; KOZONO T; PARK SD; CHUNG YS
      KCB-328 - A NOVEL CLASS-III ANTIARRHYTHMIC AGENT WITH LITTLE REVERSE FREQUENCY-DEPENDENCE IN ISOLATED GUINEA-PIG MYOCARDIUM

      Journal of cardiovascular pharmacology
    80. GJINI V; SCHREIECK J; KORTH M; WEYERBROCK S; SCHOMIG A; SCHMITT C
      FREQUENCY-DEPENDENCE IN THE ACTION OF THE CLASS-III ANTIARRHYTHMIC DRUG DOFETILIDE IS MODULATED BY ALTERING L-TYPE CALCIUM CURRENT AND DIGITALIS GLUCOSIDE

      Journal of cardiovascular pharmacology
    81. CLAYCOMB WC; LANSON NA; STALLWORTH BS; EGELAND DB; DELCARPIO JB; BAHINSKI A; IZZO NJ
      HL-1 CELLS - A CARDIAC-MUSCLE CELL-LINE THAT CONTRACTS AND RETAINS PHENOTYPIC CHARACTERISTICS OF THE ADULT CARDIOMYOCYTE

      Proceedings of the National Academy of Sciences of the United Statesof America
    82. RAMPE D; MURAWSKY MK; GRAU J; LEWIS EW
      THE ANTIPSYCHOTIC AGENT SERTINDOLE IS A HIGH-AFFINITY ANTAGONIST OF THE HUMAN CARDIAC POTASSIUM CHANNEL HERG

      The Journal of pharmacology and experimental therapeutics
    83. GEONZON R; EXNER DV; WOODMAN RC; WANG L; FENG ZP; DUFF HJ
      A HIGH-AFFINITY BINDING-SITE FOR [H-3]-DOFETILIDE ON HUMAN-LEUKOCYTES

      Journal of Molecular and Cellular Cardiology
    84. IMAMURA H; FURUKAWA Y; KASAMA M; HOYANO Y; YONEZAWA T; CHIBA S
      INHIBITION OF DELAYED RECTIFIER K-4031 DIFFERENTIALLY AFFECTS ELECTRICAL CARDIAC RESPONSES TO VAGUS STIMULATION IN ANESTHETIZED DOGS( CURRENT BY DOFETILIDE AND E)

      Japanese Journal of Pharmacology
    85. MATYUS P; BOROSY AP; VARRO A; PAPP JG; BARLOCCO D; CIGNARELLA G
      DEVELOPMENT OF PHARMACOPHORES FOR INHIBITORS OF THE RAPID COMPONENT OF THE CARDIAC DELAYED RECTIFIER POTASSIUM CURRENT

      International journal of quantum chemistry
    86. FICKER E; JAROLIMEK W; KIEHN J; BAUMANN A; BROWN AM
      MOLECULAR DETERMINANTS OF DOFETILIDE BLOCK OF HERG K+ CHANNELS

      Circulation research
    87. NATTEL S; LIU LL; STGEORGES D
      EFFECTS OF THE NOVEL ANTIARRHYTHMIC AGENT AZIMILIDE ON EXPERIMENTAL ATRIAL-FIBRILLATION AND ATRIAL ELECTROPHYSIOLOGIC PROPERTIES

      Cardiovascular Research
    88. BRIL A; FOREST MC; CHEVAL B; FAIVRE JF
      COMBINED POTASSIUM AND CALCIUM-CHANNEL ANTAGONISTIC ACTIVITIES AS A BASIS FOR NEUTRAL FREQUENCY-DEPENDENT INCREASE IN ACTION-POTENTIAL DURATION - COMPARISON BETWEEN BRL-32872 AND AZIMILIDE

      Cardiovascular Research
    89. CARMELIET E
      EFFECTS OF CETIRIZINE ON THE DELAYED K-CELLS - COMPARISON WITH TERFENADINE( CURRENTS IN CARDIAC)

      British Journal of Pharmacology
    90. SCHREIECK J; WANG YG; GJINI V; KORTH M; ZRENNER B; SCHOMIG A; SCHMITT C
      DIFFERENTIAL EFFECT OF BETA-ADRENERGIC STIMULATION ON THE FREQUENCY-DEPENDENT ELECTROPHYSIOLOGIC ACTIONS OF THE NEW CLASS-III ANTIARRHYTHMICS DOFETILIDE, AMBASILIDE, AND CHROMANOL 293B

      Journal of cardiovascular electrophysiology
    91. DARPO B; EDVARDSSON N
      EFFECTS OF ALMOKALANT, A CLASS-III ANTIARRHYTHMIC AGENT, ON SUPRAVENTRICULAR, REENTRANT TACHYCARDIAS

      Cardiovascular drugs and therapy
    92. NAIR LA; GRANT AO
      EMERGING CLASS-III ANTIARRHYTHMIC AGENTS - MECHANISM OF ACTION AND PROARRHYTHMIC POTENTIAL

      Cardiovascular drugs and therapy
    93. FIREK L; GILES WR
      ELECTROPHYSIOLOGICAL ANALYSES OF THRESHOLD CONDITIONS AND RATE-DEPENDENT FAILURE OF EXCITATION IN SINGLE MYOCYTES FROM RABBIT VENTRICLE

      Canadian journal of cardiology
    94. HOUSTON JB; CARLILE DJ
      PREDICTION OF HEPATIC-CLEARANCE FROM MICROSOMES, HEPATOCYTES, AND LIVER SLICES

      Drug metabolism reviews
    95. GOTTLIEB SS; CINES M; MARSHALL J
      TORSADES-DE-POINTES WITH ADMINISTRATION OF HIGH-DOSE INTRAVENOUS D-SOTALOL TO A PATIENT WITH CONGESTIVE-HEART-FAILURE

      Pharmacotherapy
    96. YUAN S; BLOMSTROMLUNDQVIST C; PRIPP CM; PEHRSON S; WOHLFART B; OLSSON SB
      SIGNED VALUE OF MONOPHASIC ACTION-POTENTIAL DURATION DIFFERENCE - A USEFUL MEASURE IN EVALUATION OF DISPERSION OF REPOLARIZATION IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS

      European heart journal
    97. FROST L; MORTENSEN PE; TINGLEFF J; PLATOU ES; CHRISTIANSEN EH; CHRISTIANSEN N; ERIK P; THOMSEN B; PEDERSEN AK; MOLGAARD H; CHRISTENSEN PD; WESTHEIM AS; BJORKUM K; ARENDRUP H; NIEBUHR U; JENSEN KS; ANDERSEN U
      EFFICACY AND SAFETY OF DOFETILIDE, A NEW CLASS-III ANTIARRHYTHMIC AGENT, IN ACUTE TERMINATION OF ATRIAL-FIBRILLATION OR FLUTTER AFTER CORONARY-ARTERY BYPASS-SURGERY

      International journal of cardiology
    98. CAMM AJ; ECHT D; PRATT C; MEINERTZ T; MOLLER M; SANDOE E; BLOCHTHOMSEN PE; AGNER E; EGSTRUP K; KOBER L; TORPPEDERSEN C; AURUP P; FRIEDRICH T; CARLSEN J; VIDEBAEK J; COLE D; JULIAN D; WHITEHEAD J; ANDERSEN J; FAEGERMAN O; BAGGER H; BAGGER JP; STEINMETZ E; IBSEN H; HANSEN AD; SKAGEN K; GOTZSCHE CO; NIELSEN HV; BURCHARDT H; SEIBAEK M; MARCHANT B; HANSEN S; KRISTENSEN K; GULDAGER T; HULD P; MUNSTER A; ANDERSEN S; PEDERSEN O; SIBONI A; NIELSEN T; SAEKMOSE S; POULSEN K; LINDSKOV J; AVER P; ANDERSEN HH; SORENSEN BK; ANDERSEN HA; MARKENVARD J; HANSEN KN; FRANDSEN F; HUMBURG K; JENSEN AL; SOSTED U; KNUDSEN BM; HOLMGAARD P; LYNGBORG K; JACOBSEN TJ; KRISTENSEN GS; SYKULSKI R; HILDEBRANDT P; RAA D; KJAERGAARD J; DEPCIK H; VESTERGAARD S; SONDERGAARD J; ORLOWITZ S; OLSEN E; LARSSON J; HANSEN PF; MAINZ H; MELCHIOR T; ELMING H; LOEHR D; JORGENSEN U; BUCHWALD C; ROKKEDAL J; ZABEL S; JORGENSEN A; PLESS P; BULOW M; GAMMELGAARD FJ; LUND B; KRISTENSEN T; ORLOFF P; BRANDT D; JENSEN SE; POULSEN SH; FRIIS E; MYGIND L; MUNK L; JENSEN LE; RYNNING B; RALFKIAER N; JORGENSEN H; WINTHER M; KANTERS J; ABILDSTROM SZ; WIEMANN O; HORNUM L; HERLEV KAS; NELAND K; HOST U; GRONNING H; THERKELSEN A; KLARHOLT E; KACZAN M; VEJBYCHRISTENSEN H; NIEMANN T; MOURITSEN E; LODAHL DB; HAGGER K; PEDERSEN F; MADSEN J; DOMINGUEZ H; STEIG B; BORRING M; PETERSEN EL; SEJERSEN H; PETERSEN J; MORK H; JENSEN B; JOHANSEN I; PETERSEN M; HANSEN D; FROST J; TOUBRO N; HANSEN JF; JENSEN GVH; SORUM C; FREDERIKSEN M; SAJDIEH A; SKOV N; MOLGAARD S; MEIER K; KAISER P; BRENDRUP B; BLAK AK; HOLMGAARD B; NIELSEN M; JOHANNESEN A; LINDBJERG J; LARSEN A; WULFF B; JORGENSEN L; SCHEIBEL M; HAAHR S; LILLOR K; FENGER A; ASKLUND M; BJERRE K; GYLDENKERNE N; BUHL S; FELDTHAUS B; METAIS I; GARDE K; CHRISTENSEN S; RASMUSSEN B; RASMUSSEN SL; NIELSEN G; HELO O; CHRISTENSEN I; LUND B; GLUD T; MOLLER BB; GLESNER P; SVENDSEN TL; MADSEN H; RAYMOND I; LARSEN J; ELIN P; JENSEN BS; HINTZE U; HAGHFELT T; VILLADSEN H; THOMSEN KK; GANDRUP U; ROSENLUND I; PAARUP L; HALSE J; NIELSEN I; THORBALL N; MOGELVANG J; LARSEN I; TRUESEN S; KJOLLER E; HEIBERG J; CHRISTIANSEN K; DREWES VM; STENTEBJERG SE; POULSEN J; BUHL J; LUCKOW A; ANDERSEN L; KJELDSEN L; STENTEBJERG A; KRISTENSEN H; ELIASEN P; LESSING M; MAERKEDAL H; NORHOLM C; NIELSEN M; GJORUP T; NIELSEN H; BRINCH EA; SKOV JB; HEMPEL H; EGEDE F; RASMUSSEN OB; MARLEY M; JENSEN IF; PETERSEN J; FISHER T; THOMSEN NK; RIGGELSEN T; MARCUSSEN C; BRONS M; SIMONSEN E; ANDERSEN J; ANDERSEN B; EICHORST R; LAURIDSEN M; ALBRECHTSEN E; DORFF B; ANDERSEN HB; CALLESEN L; DEDING A; TANGO M; ZEUTHEN E; JOHANSEN PB; NIELSEN PF; MARTINSEN K; VIGH L; FRANDSEN K; LEDERBALLE O; NIELSEN HK; MALCZYNSKE J; RAUNGAARD B; NYVAD O; BENN M; BERG S; KRISTENSEN SD; GOTZSCHE C; SONDERGAARD E; SONDERGAARD B; LARSEN A; HANSEN HT; SKRIVER L; WESTERGAARD M; HANSEN AL; BJORN M; MUNKSGAARD D; BRENDSTRUP C; KARLSEN S; CARLSEN N; HOUE K; DEELA C; ANDERSEN H; KROGSTRUP L; PEDERSEN N; WENDT N; AGERHOLM L; ANDERSEN IM; JOHANSEN L; LUNDBERG S; NIELSEN L; SNORGAARD M; TVESKOV H; FRIEDRICH T; DALRYMPLE I; WHITE S; INGAMELLS A; ANDREWS G; HILTON C; KENT C; STEADMAN J; HART J; COE R; WARWICK V; SMITH K; FOWLER G; HOLMAN L; COE A; COMPTON A; OAKES L; WEARING A; JACKSON V; NELSON G; MCDOWELL P; EAST M; MCDOWELL L; BASI M; DONNELLY P; NITSCHMAN P; SOLCA AM; FARBRACE P; TREBBLE A; SHEPHERD S; DIGHT B
      DOFETILIDE IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AND EITHER HEART-FAILURE OR ACUTE MYOCARDIAL-INFARCTION - RATIONALE, DESIGN, AND PATIENT CHARACTERISTICS OF THE DIAMOND STUDIES

      Clinical cardiology
    99. WEYERBROCK S; SCHREIECK J; KARCH M; OVERBECK M; MEISNER H; KEMKES B; SCHOMIG A; SCHMITT C
      RATE-INDEPENDENT EFFECTS OF THE NEW CLASS-III ANTIARRHYTHMIC AGENT AMBASILIDE ON TRANSMEMBRANE ACTION-POTENTIALS IN HUMAN VENTRICULAR ENDOMYOCARDIUM

      Journal of cardiovascular pharmacology
    100. KOBAYASHI Y; ATARASHI H; INO T; KURUMA A; NOMURA A; SAITOH H; HAYAKAWA H
      CLINICAL AND ELECTROPHYSIOLOGIC EFFECTS OF DOFETILIDE IN PATIENTS WITH SUPRAVENTRICULAR TACHYARRHYTHMIAS

      Journal of cardiovascular pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 01:25:21